Skip to content

Testing for the first time the effects of a new medicine in healthy people

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507880-20-00
Acronym
SYN510CT01
Enrollment
72
Registered
2024-01-15
Start date
2024-02-05
Completion date
2024-10-21
Last updated
2024-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychatric disorder

Interventions

None listed

Sponsors

Eurofins Optimed, Synendos Therapeutics AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026